Intravenous Heparin as an Adjunct for the Treatment of Anaphylactic Reactions in an Emergency Department
Status:
Withdrawn
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
To determine if intravenous unfractionated heparin (with standard therapy) for treatment of
anaphylaxis results in faster time to recovery.
Phase:
N/A
Details
Lead Sponsor:
Truman Medical Center University of Missouri, Kansas City
Collaborators:
American College of Emergency Physicians Emergency Physicians Foundation of KC Saint Luke's Hospital Truman Medical Center University of Missouri, Kansas City